solara active pharma sciences
Jump to
17 Results Found
  • Solara Active Pharma shares gain 7% as CEP for Ranitidine Hydrochloride is restored by EU regulator Jul 02, 2021 03:18 PM IST

    Solara Active Pharma shares gain 7% as CEP for Ranitidine Hydrochloride is restored by EU regulator

    The share touched a 52-week high of Rs 1,859.30 and a 52-week low of Rs 622.20 on May 19, 2021 and July 16, 2020, respectively.

  • SOLARA ACTIVE P Standalone March 2021 Net Sales at Rs 444.21 crore, up 49.68% Y-o-Y May 11, 2021 11:11 AM IST

    SOLARA ACTIVE P Standalone March 2021 Net Sales at Rs 444.21 crore, up 49.68% Y-o-Y

  • SOLARA ACTIVE P Consolidated March 2021 Net Sales at Rs 444.21 crore, up 49.68% Y-o-Y May 07, 2021 08:37 AM IST

    SOLARA ACTIVE P Consolidated March 2021 Net Sales at Rs 444.21 crore, up 49.68% Y-o-Y

  • Buy Solara Active Pharma Sciences: target of Rs 1730: Sharekhan Apr 13, 2021 10:37 AM IST

    Buy Solara Active Pharma Sciences: target of Rs 1730: Sharekhan

    Sharekhan is bullish on Solara Active Pharma Sciences has recommended buy rating on the stock with a target price of Rs 1730 in its research report dated April 12, 2021.

  • Buy Solara Active Pharma Sciences; target of Rs 1700: Sharekhan Feb 09, 2021 10:47 PM IST

    Buy Solara Active Pharma Sciences; target of Rs 1700: Sharekhan

    Sharekhan is bullish on Solara Active Pharma Sciences has recommended buy rating on the stock with a target price of Rs 1700 in its research report dated February 03, 2021.

  • SOLARA ACTIVE P Standalone December 2020 Net Sales at Rs 426.69 crore, up 24.15% Y-o-Y Feb 05, 2021 09:22 AM IST

    SOLARA ACTIVE P Standalone December 2020 Net Sales at Rs 426.69 crore, up 24.15% Y-o-Y

  • SOLARA ACTIVE P Standalone December 2020 Net Sales at Rs 426.69 crore, up 24.15% Y-o-Y Feb 03, 2021 04:11 PM IST

    SOLARA ACTIVE P Standalone December 2020 Net Sales at Rs 426.69 crore, up 24.15% Y-o-Y

  • Buy Solara Active Pharma Sciences: target of Rs 1450 : Sharekhan Dec 09, 2020 01:45 PM IST

    Buy Solara Active Pharma Sciences: target of Rs 1450 : Sharekhan

    Sharekhan is bullish on Solara Active Pharma Sciences recommended buy rating on the stock with a target price of Rs 1450 in its research report dated December 08, 2020.

  • Buy Solara Active Pharma Sciences: target of Rs 1371: Sharekhan Nov 05, 2020 05:00 PM IST

    Buy Solara Active Pharma Sciences: target of Rs 1371: Sharekhan

    Sharekhan is bullish on Solara Active Pharma Sciences recommended buy rating on the stock with a target price of Rs 1371 in its research report dated October 30, 2020.

  • Buy Solara Active Pharma Sciences; target of Rs 1371: Sharekhan Nov 02, 2020 03:10 PM IST

    Buy Solara Active Pharma Sciences; target of Rs 1371: Sharekhan

    Sharekhan is bullish on Solara Active Pharma Sciences recommended buy rating on the stock with a target price of Rs 1371 in its research report dated October 30, 2020.

  • SOLARA ACTIVE P Standalone September 2020 Net Sales at Rs 397.56 crore, up 13.47% Y-o-Y Oct 30, 2020 05:00 PM IST

    SOLARA ACTIVE P Standalone September 2020 Net Sales at Rs 397.56 crore, up 13.47% Y-o-Y

  • SOLARA ACTIVE P Standalone June 2020 Net Sales at Rs 348.42 crore, up 10.93% Y-o-Y Aug 04, 2020 09:15 AM IST

    SOLARA ACTIVE P Standalone June 2020 Net Sales at Rs 348.42 crore, up 10.93% Y-o-Y

  • Solara Active Pharma share price rises 3% on merger nod Dec 24, 2019 12:57 PM IST

    Solara Active Pharma share price rises 3% on merger nod

    SCPL and the company are both engaged in the manufacture and sale of active pharmaceutical ingredients for the pharmaceutical industry.

  • Ranitidine controversy: Which Indian pharma companies stand to lose? Sep 30, 2019 02:12 PM IST

    Ranitidine controversy: Which Indian pharma companies stand to lose?

  • Ideas for Profit | An API company that combines good growth prospects with reasonable valuations Jul 01, 2019 09:53 AM IST

    Ideas for Profit | An API company that combines good growth prospects with reasonable valuations

  • SOLARA ACTIVE P Standalone March 2019 Net Sales at Rs 380.10 crore, up 0% Y-o-Y May 16, 2019 04:22 PM IST

    SOLARA ACTIVE P Standalone March 2019 Net Sales at Rs 380.10 crore, up 0% Y-o-Y

  • SOLARA ACTIVE P standalone Jun-2018 sales at Rs 302.81 crore Aug 03, 2018 03:38 PM IST

    SOLARA ACTIVE P standalone Jun-2018 sales at Rs 302.81 crore

    SOLARA ACTIVE PHARMA SCIENCES has reported a sales total income from operations of Rs 302.81 crore and a net profit of Rs 2.98 crore for the quarter ended Jun-2018

Sections
ISO 27001 - BSI Assurance Mark